tiprankstipranks
Advertisement
Advertisement

Accelerate Diagnostics reports preliminary FY23 revenue$12.1M, consensus $12.81M

Expects to end the year with approximately $13.4M in cash and cash equivalents, representing net cash used in the fourth quarter of approximately $7.8M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on AXDX:

Disclaimer & DisclosureReport an Issue

1